Cargando…
CD40-Activated B Cell Cancer Vaccine Improves Second Clinical Remission and Survival in Privately Owned Dogs with Non-Hodgkin's Lymphoma
Cell-based active immunotherapy for cancer is a promising novel strategy, with the first dendritic cell (DC) vaccine achieving regulatory approval for clinical use last year. Manufacturing remains arduous, especially for DC vaccines, and the prospect of using cell-based immunotherapy in the adjuvant...
Autores principales: | Sorenmo, Karin U., Krick, Erika, Coughlin, Christina M., Overley, Beth, Gregor, Thomas P., Vonderheide, Robert H., Mason, Nicola J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164165/ https://www.ncbi.nlm.nih.gov/pubmed/21904611 http://dx.doi.org/10.1371/journal.pone.0024167 |
Ejemplares similares
-
Successful Phenotype Improvement following Gene Therapy for Severe Hemophilia A in Privately Owned Dogs
por: Callan, Mary Beth, et al.
Publicado: (2016) -
A national survey of Ixodidae ticks on privately owned dogs in Italy
por: Maurelli, Maria Paola, et al.
Publicado: (2018) -
Occurrence of strongyloidiasis in privately owned and sheltered dogs: clinical presentation and treatment outcome
por: Paradies, Paola, et al.
Publicado: (2017) -
My Own Private Ishkabibble
por: Comfort, Nathaniel
Publicado: (2014) -
Privately owned public space : the New York City experience
por: Kayden, Jerold S.
Publicado: (2000)